Healthcare of Ontario Pension Plan Trust Fund Makes New $43.74 Million Investment in Henry Schein, Inc. (NASDAQ:HSIC)

Healthcare of Ontario Pension Plan Trust Fund bought a new stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 600,000 shares of the company's stock, valued at approximately $43,740,000. Healthcare of Ontario Pension Plan Trust Fund owned about 0.48% of Henry Schein as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. American Century Companies Inc. boosted its position in Henry Schein by 3.1% during the second quarter. American Century Companies Inc. now owns 5,484,286 shares of the company's stock valued at $351,543,000 after buying an additional 162,477 shares during the period. FMR LLC boosted its position in Henry Schein by 7.8% during the third quarter. FMR LLC now owns 3,280,890 shares of the company's stock valued at $239,177,000 after buying an additional 237,888 shares during the period. Nuance Investments LLC boosted its position in Henry Schein by 22.3% during the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company's stock valued at $166,072,000 after buying an additional 414,748 shares during the period. Burgundy Asset Management Ltd. boosted its position in Henry Schein by 1.0% during the second quarter. Burgundy Asset Management Ltd. now owns 1,640,379 shares of the company's stock valued at $105,148,000 after buying an additional 16,476 shares during the period. Finally, Dimensional Fund Advisors LP boosted its position in Henry Schein by 10.1% during the second quarter. Dimensional Fund Advisors LP now owns 1,634,384 shares of the company's stock valued at $104,764,000 after buying an additional 149,517 shares during the period. Institutional investors own 96.62% of the company's stock.

Henry Schein Stock Up 0.5 %

Shares of NASDAQ HSIC traded up $0.38 on Thursday, reaching $77.66. 832,776 shares of the company's stock traded hands, compared to its average volume of 1,400,600. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.63. The business's 50 day simple moving average is $71.26 and its two-hundred day simple moving average is $69.84. The company has a market cap of $9.68 billion, a price-to-earnings ratio of 31.96, a price-to-earnings-growth ratio of 2.20 and a beta of 0.87. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating analysts' consensus estimates of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter last year, the firm earned $1.32 earnings per share. The business's revenue for the quarter was up .4% on a year-over-year basis. As a group, equities research analysts forecast that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Insider Buying and Selling at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the firm's stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares of the company's stock, valued at $4,978,026.90. This trade represents a 22.65 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Michael S. Ettinger sold 12,240 shares of the firm's stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the sale, the chief operating officer now directly owns 87,706 shares of the company's stock, valued at $6,577,950. This trade represents a 12.25 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on HSIC. JPMorgan Chase & Co. dropped their target price on shares of Henry Schein from $88.00 to $80.00 and set an "overweight" rating for the company in a report on Monday, August 12th. Evercore ISI increased their target price on shares of Henry Schein from $70.00 to $74.00 and gave the stock an "in-line" rating in a report on Tuesday, October 8th. StockNews.com upgraded shares of Henry Schein from a "sell" rating to a "hold" rating in a report on Thursday, November 7th. Robert W. Baird dropped their target price on shares of Henry Schein from $92.00 to $82.00 and set an "outperform" rating for the company in a report on Wednesday, August 7th. Finally, Barrington Research reiterated an "outperform" rating and set a $82.00 target price on shares of Henry Schein in a report on Wednesday, November 6th. Six investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Henry Schein currently has a consensus rating of "Moderate Buy" and a consensus price target of $79.38.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.